Die Biotest AG erhält ein Einberufungsverlangen von Grifols S.A. für eine außerordentliche Hauptversammlung^EQS-News: Biotest AG / Schlagwort(e): RechtssacheDie Biotest AG…
Brookfield Asset Management Ltd. has revived talks with Grifols SA’s main shareholder about a potential offer for the Spanish blood-plasma…
Spanish drugmaker Grifols SA is poised for its worst year on record, but some analysts aren’t ready yet to give…
The US dropped its investigation into General Industrial Partners LLP, the parent company of Gotham City Research, which accused drug…
For hedge fund Mason Capital Management LLC, much of what ails Grifols SA can be laid at the door of…
On Wednesday, Grifols SA (NASDAQ:GRFS) said it ended discussions with Brookfield Capital Partners (UK) Limited about a potential acquisition. This…
The embattled Spanish drugmaker Grifols SA is in talks with banks to refinance bonds due next year and extend a…
Brookfield Asset Management Ltd. is preparing to walk away from a plan to acquire Grifols SA over disagreements on valuation…
Banks are getting ready to submit final offers to Brookfield Asset Management for a debt package of about €11 billion…
Brookfield Asset Management will request more time to conduct due diligence on Grifols SA, as it seeks to take the…
A group of Grifols SA investors including Flat Footed LLC, Mason Capital Management LLC and Sachem Head Capital Management LP…
Spanish drugmaker Grifols SA, the target of a short-seller attack earlier in the year, is seeking to hire an external…
Some large Grifols SA shareholders are increasing pressure on the Spanish blood plasma firm to seek a substantial premium in…
Brookfield Asset Management is asking banks to backstop up to €9.5 billion ($10.6 billion) of debt for its potential take-private…
Spain’s Grifols SA is set to report an unexpected accounting adjustment related to its stake in Shanghai RAAS, according to…
Scranton Enterprises, a major shareholder of Spanish pharmaceutical company Grifols SA, is in talks with Oaktree Capital Management for a…
A well-publicized short bet by General Industrial Partners on Spanish company Grifols SA helped the hedge fund earn double-digit gains…
NEW YORK, March 31, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages GRFS American Depositary Receipt Investors with Substantial Losses to Contact Firm HAGENS BERMAN, NATIONAL…
NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
Spanish securities regulators said they didn’t find any big mistakes in Grifols SA’s financial reports, though the pharmaceutical company does…
Grifols SA shares rallied from multiyear lows after an auditor signed off on the annual accounts of the Spanish plasma…
In the weeks following a short seller attack earlier this year, analysts mostly stood behind Spanish blood plasma firm Grifols…
RADNOR, Pa., March 01, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP…